Back to top
more

Encompass Health (EHC)

(Delayed Data from NYSE)

$94.50 USD

94.50
426,967

-0.23 (-0.24%)

Updated Oct 4, 2024 04:00 PM ET

After-Market: $94.48 -0.02 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 18% (45 out of 252)

Industry: Medical - Outpatient and Home Healthcare

Better trading starts here.

Zacks News

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here's Why You Should Retain Universal Health (UHS) Stock Now

Universal Health (UHS) benefits from improving patient volumes, sound segmental performance and a solid capital position.

Encompass Health (EHC) Up 41% in a Year: More Room for Growth?

Encompass Health (EHC) is well-poised for growth on the back of growing revenues, an aging U.S. population, joint ventures and solid cash reserves.

Is Encompass Health (EHC) Stock Outpacing Its Medical Peers This Year?

Here is how Encompass Health (EHC) and Eton Pharmaceuticals, Inc. (ETON) have performed compared to their sector so far this year.

Is ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM) a Strong ETF Right Now?

Smart Beta ETF report for OUSM

Tenet Healthcare (THC) & Oracle Unite to Improve Efficiency

Tenet Healthcare (THC) collaborates with Oracle Cloud HCM to improve and automate human resources and payroll processes.

Encompass Health (EHC) Opens JV Hospital With Piedmont in Georgia

The Rehabilitation Hospital of Columbus is Encompass Health's (EHC) sixth location in the state of Georgia.

Waters (WAT) Walk-Up Solutions Boost Bioprocess Development

Waters (WAT) launches new bioprocess walk-up solutions, automating sample prep and analysis from any bioreactor.

Zacks Industry Outlook Highlights DaVita, Encompass Health, Option Care Health and RadNet

DaVita, Encompass Health, Option Care Health and RadNet are part of the Zacks Industry Outlook article.

Factors That Make Molina Healthcare (MOH) an Attractive Bet Now

Molina Healthcare (MOH) remains well-poised for growth on a growing customer base, acquisitions and solid cash reserves.

4 Stocks to Buy in a Booming Outpatient Home Health Industry

Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, EHC, OPCH and RDNT are well-poised to gain.

Encompass Health (EHC) Up 2.9% Since Last Earnings Report: Can It Continue?

Encompass Health (EHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Humana (HUM) to Provide In-home Care With Primary Care Anywhere

Humana (HUM) enhances its CenterWell brand with the launch of Primary Care Anywhere.

Humana (HUM) to Bring Enhanced Kidney Care to MA Members

Humana (HUM) makes Interwell's extensive resources available to its MA members grappling with CKD and ESKD, and hence bring about better health outcomes for them.

Urmimala Biswas headshot

5 Lucrative PEG-Based GARP Stocks for Investors

Here are the five stocks that meet our screening criteria - PRDO, EHC, OSK, HSBC and PHM.

Nilanjan Choudhury headshot

5 Growth Opportunities Thriving on Relative Price Strength

HURN, EHC, RDY, BOOM and HWKN are five stocks with explosive relative price strength.

Here's Why Encompass Health (EHC) Stock is a Strong Buy Now

Encompass Health's (EHC) focus on boosting the number of licensed beds and hospitals will likely enhance market density and build scale.

Universal Health (UHS) Gains From Solid Segmental Performance

Universal Health (UHS) gains from the uptrend in revenue growth, which in turn, is derived from expanding patient volumes. A credible financial position drives its expansion endeavors.

Brookdale Senior (BKD) Shares Jump 18.7% Since Q2 Earnings Beat

Brookdale Senior (BKD) expects adjusted EBITDA to be within the $73-$78 million range in the third quarter.

Zacks.com featured highlights Alibaba, Encompass Health, Molson Coors, Ford Motor and Albemarle

Alibaba, Encompass Health, Molson Coors, Ford Motor and Albemarle have been highlighted in this Screen of The Week article.

The Joint (JYNT) Reaches 900th Clinic Mark With New Texas Unit

The Joint (JYNT) moves from the 800th to the 900th clinic milestone in less than a year.

Urmimala Biswas headshot

5 Lucrative Value Picks Based on Discounted PEG

Here are five stocks that match our screening criteria, BABA, EHC, TAP, F and ALB.

Encompass Health's (EHC) Q2 Earnings Beat, '23 EPS View Raised

Encompass Health's (EHC) Q2 results reflect a growing patient base and improved net patient revenue per discharge. Management anticipates 2023 adjusted EPS within $3.31-$3.53, up from the earlier view of $2.94-$3.23.

Shaun Pruitt headshot

Here's Why Investors Should Buy These 2 Medical Stocks After Earnings

Following their favorable Q2 reports now looks like a good time to buy Encompass Health (EHC) and Vertex Pharmaceuticals (VRTX) stock.